Transcenta Holding Limited (HKG:6628)
Hong Kong
· Delayed Price · Currency is HKD 1.250
+0.030 (2.46%)
May 2, 2025, 4:08 PM HKT
Transcenta Holding Revenue
In the year 2024, Transcenta Holding had annual revenue of 11.26M CNY, down -79.09%. Transcenta Holding had revenue of 6.70M in the half year ending December 31, 2024, a decrease of -91.64%.
Revenue
11.26M CNY
Revenue Growth
-79.09%
P/S Ratio
42.33
Revenue / Employee
61.20K CNY
Employees
184
Market Cap
507.30M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Alibaba Health Information Technology | 31.39B |
| Akeso | 2.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |